Liquid biopsy for diffuse intrinsic pontine glioma: An update

Victor M. Lu, Erica A. Power, Liang Zhang, David J. Daniels

Research output: Contribution to journalReview article

Abstract

Diffuse intrinsic pontine glioma (DIPG), otherwise known as diffuse midline glioma with H3K27M mutation, is a devastating brainstem glioma without a cure. Efforts are currently underway to better optimize molecular diagnoses through biological sampling, which today remains largely limited to surgical biopsy sampling. Surgical intervention is not without its risks, and therefore a preference remains for a less invasive modality that can provide biological information about the tumor. There is emerging evidence to suggest that a liquid biopsy, targeting biofluids such as CSF and blood plasma, presents an attractive alternative for brain tumors in general. In this update, the authors provide a summary of the progress made to date regarding the use of liquid biopsy to diagnose and monitor DIPG, and they also propose future development and applications of this technique moving forward, given its unique histone biology.

Original languageEnglish (US)
Pages (from-to)593-600
Number of pages8
JournalJournal of Neurosurgery: Pediatrics
Volume24
Issue number5
DOIs
StatePublished - Jan 1 2019

Fingerprint

Glioma
Biopsy
Brain Neoplasms
Histones
Brain Stem
Mutation
Neoplasms

Keywords

  • Biomarkers
  • Diffuse intrinsic pontine glioma
  • DIPG
  • Epigenetic
  • H3K27M
  • Liquid biopsy
  • Oncology

ASJC Scopus subject areas

  • Surgery
  • Pediatrics, Perinatology, and Child Health
  • Clinical Neurology

Cite this

Liquid biopsy for diffuse intrinsic pontine glioma : An update. / Lu, Victor M.; Power, Erica A.; Zhang, Liang; Daniels, David J.

In: Journal of Neurosurgery: Pediatrics, Vol. 24, No. 5, 01.01.2019, p. 593-600.

Research output: Contribution to journalReview article

Lu, Victor M. ; Power, Erica A. ; Zhang, Liang ; Daniels, David J. / Liquid biopsy for diffuse intrinsic pontine glioma : An update. In: Journal of Neurosurgery: Pediatrics. 2019 ; Vol. 24, No. 5. pp. 593-600.
@article{b730231eb6ea4363815568a0a0e8c0c2,
title = "Liquid biopsy for diffuse intrinsic pontine glioma: An update",
abstract = "Diffuse intrinsic pontine glioma (DIPG), otherwise known as diffuse midline glioma with H3K27M mutation, is a devastating brainstem glioma without a cure. Efforts are currently underway to better optimize molecular diagnoses through biological sampling, which today remains largely limited to surgical biopsy sampling. Surgical intervention is not without its risks, and therefore a preference remains for a less invasive modality that can provide biological information about the tumor. There is emerging evidence to suggest that a liquid biopsy, targeting biofluids such as CSF and blood plasma, presents an attractive alternative for brain tumors in general. In this update, the authors provide a summary of the progress made to date regarding the use of liquid biopsy to diagnose and monitor DIPG, and they also propose future development and applications of this technique moving forward, given its unique histone biology.",
keywords = "Biomarkers, Diffuse intrinsic pontine glioma, DIPG, Epigenetic, H3K27M, Liquid biopsy, Oncology",
author = "Lu, {Victor M.} and Power, {Erica A.} and Liang Zhang and Daniels, {David J.}",
year = "2019",
month = "1",
day = "1",
doi = "10.3171/2019.6.PEDS19259",
language = "English (US)",
volume = "24",
pages = "593--600",
journal = "Journal of neurosurgery. Pediatrics",
issn = "1933-0707",
publisher = "American Association of Neurological Surgeons",
number = "5",

}

TY - JOUR

T1 - Liquid biopsy for diffuse intrinsic pontine glioma

T2 - An update

AU - Lu, Victor M.

AU - Power, Erica A.

AU - Zhang, Liang

AU - Daniels, David J.

PY - 2019/1/1

Y1 - 2019/1/1

N2 - Diffuse intrinsic pontine glioma (DIPG), otherwise known as diffuse midline glioma with H3K27M mutation, is a devastating brainstem glioma without a cure. Efforts are currently underway to better optimize molecular diagnoses through biological sampling, which today remains largely limited to surgical biopsy sampling. Surgical intervention is not without its risks, and therefore a preference remains for a less invasive modality that can provide biological information about the tumor. There is emerging evidence to suggest that a liquid biopsy, targeting biofluids such as CSF and blood plasma, presents an attractive alternative for brain tumors in general. In this update, the authors provide a summary of the progress made to date regarding the use of liquid biopsy to diagnose and monitor DIPG, and they also propose future development and applications of this technique moving forward, given its unique histone biology.

AB - Diffuse intrinsic pontine glioma (DIPG), otherwise known as diffuse midline glioma with H3K27M mutation, is a devastating brainstem glioma without a cure. Efforts are currently underway to better optimize molecular diagnoses through biological sampling, which today remains largely limited to surgical biopsy sampling. Surgical intervention is not without its risks, and therefore a preference remains for a less invasive modality that can provide biological information about the tumor. There is emerging evidence to suggest that a liquid biopsy, targeting biofluids such as CSF and blood plasma, presents an attractive alternative for brain tumors in general. In this update, the authors provide a summary of the progress made to date regarding the use of liquid biopsy to diagnose and monitor DIPG, and they also propose future development and applications of this technique moving forward, given its unique histone biology.

KW - Biomarkers

KW - Diffuse intrinsic pontine glioma

KW - DIPG

KW - Epigenetic

KW - H3K27M

KW - Liquid biopsy

KW - Oncology

UR - http://www.scopus.com/inward/record.url?scp=85074503701&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85074503701&partnerID=8YFLogxK

U2 - 10.3171/2019.6.PEDS19259

DO - 10.3171/2019.6.PEDS19259

M3 - Review article

C2 - 31491754

AN - SCOPUS:85074503701

VL - 24

SP - 593

EP - 600

JO - Journal of neurosurgery. Pediatrics

JF - Journal of neurosurgery. Pediatrics

SN - 1933-0707

IS - 5

ER -